Alpha Tau Medical to Present at Jefferies Radiopharma Summit
Ticker: DRTSW · Form: 6-K · Filed: Mar 25, 2024 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: presentation, radiopharma, conference
TL;DR
Alpha Tau Medical presenting at Jefferies Radiopharma Summit on March 25, 2024.
AI Summary
On March 25, 2024, Alpha Tau Medical Ltd. announced its participation in the Jefferies Radiopharma Innovation Summit. The company, headquartered in Jerusalem, Israel, will present at this event, which focuses on advancements in radiopharmaceuticals.
Why It Matters
This presentation provides Alpha Tau Medical an opportunity to showcase its technology and progress to key investors and industry participants in the radiopharma sector.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in an industry event, which typically carries low immediate risk.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- Jefferies Radiopharma Innovation Summit (event) — Event Alpha Tau will present at
- March 25, 2024 (date) — Date of press release
FAQ
What is the purpose of Alpha Tau Medical's participation in the Jefferies Radiopharma Innovation Summit?
The purpose is to present at the summit, as indicated by the press release title issued on March 25, 2024.
When was the press release regarding the summit presentation issued?
The press release was issued on March 25, 2024.
What is the exact name of the company filing this report?
The exact name of the registrant is Alpha Tau Medical Ltd.
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Jerusalem, Israel.
What form is Alpha Tau Medical Ltd. filing?
Alpha Tau Medical Ltd. is filing a Form 6-K.
Filing Stats: 336 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-03-25 08:32:07
Filing Documents
- ea0202282-6k_alphataumed.htm (6-K) — 12KB
- ea0202282ex99-1_alphatau.htm (EX-99.1) — 6KB
- 0001213900-24-025298.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: March 25, 2024 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer